Product Code: ETC8548231 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Sarcopenia Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Sarcopenia Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Sarcopenia Market - Industry Life Cycle |
3.4 Netherlands Sarcopenia Market - Porter's Five Forces |
3.5 Netherlands Sarcopenia Market Revenues & Volume Share, By Supplement Type, 2021 & 2031F |
3.6 Netherlands Sarcopenia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Sarcopenia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in the Netherlands leading to a higher prevalence of sarcopenia |
4.2.2 Growing awareness and focus on preventive healthcare and wellness among the population |
4.2.3 Technological advancements in diagnostic tools and treatment options for sarcopenia |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for sarcopenia-related treatments and therapies |
4.3.2 Lack of standardized diagnostic criteria and awareness among healthcare professionals |
4.3.3 High costs associated with advanced diagnostic tools and treatment options |
5 Netherlands Sarcopenia Market Trends |
6 Netherlands Sarcopenia Market, By Types |
6.1 Netherlands Sarcopenia Market, By Supplement Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Sarcopenia Market Revenues & Volume, By Supplement Type, 2021- 2031F |
6.1.3 Netherlands Sarcopenia Market Revenues & Volume, By Protein Supplement, 2021- 2031F |
6.1.4 Netherlands Sarcopenia Market Revenues & Volume, By Vitamin D & Calcium Supplement, 2021- 2031F |
6.1.5 Netherlands Sarcopenia Market Revenues & Volume, By Vitamin B12 Supplement, 2021- 2031F |
6.2 Netherlands Sarcopenia Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Sarcopenia Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Netherlands Sarcopenia Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 Netherlands Sarcopenia Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2.5 Netherlands Sarcopenia Market Revenues & Volume, By Hypermarket & Supermarket, 2021- 2031F |
7 Netherlands Sarcopenia Market Import-Export Trade Statistics |
7.1 Netherlands Sarcopenia Market Export to Major Countries |
7.2 Netherlands Sarcopenia Market Imports from Major Countries |
8 Netherlands Sarcopenia Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for sarcopenia patients |
8.2 Percentage of healthcare professionals trained in sarcopenia diagnosis and management |
8.3 Number of research studies and clinical trials focused on sarcopenia treatments and outcomes |
9 Netherlands Sarcopenia Market - Opportunity Assessment |
9.1 Netherlands Sarcopenia Market Opportunity Assessment, By Supplement Type, 2021 & 2031F |
9.2 Netherlands Sarcopenia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Sarcopenia Market - Competitive Landscape |
10.1 Netherlands Sarcopenia Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Sarcopenia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |